Polyphenols (Various).

Tea, coffee and other phenol-rich foods bind non-heme iron in the gut lumen and cut its absorption from the same meal, sometimes substantially. The effect is chemical and immediate, and it is the reason iron doses are separated from tea and coffee by a couple of hours. It applies to non-heme iron far more than to heme iron. This is about a single meal's absorption, not a claim about iron status over time.

Ascorbate reduces flavonoid phenoxyl radicals back to the parent phenol, and it also reduces ferric to ferrous iron, which partly offsets the chelation problem above. Those are two separate well-described chemistries that happen to run in the same direction for formulators. The redox recycling is a solution-phase observation. The iron effect is measured in absorption studies.

Only a small share of ingested polyphenols is absorbed in the small intestine. The rest arrives in the colon where bacterial enzymes cleave glycosides and open rings, producing phenolic acids and metabolites such as urolithins and equol that are what actually circulate. Because the required bacteria are not present in everyone, response to a fixed polyphenol dose varies widely between people. Whether adding a specific probiotic strain reliably shifts that conversion in humans is not settled.

A systematic review of polyphenol supplementation reported shifts in gut microbiota composition and in fecal short-chain fatty acids, the same endpoint fermentable fibres move. Combining the two gives the colon two substrate types rather than one. These are microbial and fecal markers, not clinical outcomes. The combination itself has not been isolated in a trial.

Dissolution limits uptake for the lipophilic end of the polyphenol range, and a lipid vehicle keeps those compounds in solution through the upper gut. It does nothing for the water-soluble glycosides, which have the opposite problem. Match the vehicle to the specific polyphenol rather than applying it to the class. This is formulation pharmaceutics, not a clinical finding.

The same catechol groups that bind iron bind copper. In cell-free systems those complexes can generate rather than quench radicals, which is why high phenolic doses do not behave like simple antioxidants in every assay. What this means for a person taking both is not established. It is a reason to space a copper dose from a phenol-heavy drink.

Condensed tannins and other high molecular weight phenolics bind protein and precipitate it, which is what produces astringency in tea and red wine. In a beverage that means haze and sediment when a polyphenol extract meets a protein powder. It also lowers the amount of free phenolic left in solution. This is a formulation problem first and a bioavailability question second.

Flavonoids compete for the same UGT and SULT isoforms, so stacking several at high dose changes the metabolite profile of each. That can raise the free fraction of one compound while lowering another, in ways that are hard to predict from the individual doses. The competition itself is well characterised in vitro. The net human consequence for a given blend is not.

Green tea, coffee and cocoa deliver polyphenols and caffeine together, so most human data on those foods cannot separate the two. A trial of a whole coffee cherry extract reported improved time trial performance, and that product carries both. Attributing such a result to the polyphenol fraction alone is not supportable. Where a formula uses a decaffeinated extract, the caffeine-driven part of any food-based evidence no longer applies.